Windlas Biotech - Quaterly Results

08 Nov 2022 Evaluate
The company witnessed a 15.17% growth in the revenue at Rs. 1327.30 millions for the quarter ended September 2022 as compared to Rs. 1152.52 millions during the year-ago period.The company has announced a 46.64% increase in its profits to Rs . 122.09  millions for the  quarter ended September 2022 compared to Rs. 83.26 millions in the corresponding quarter in the previous year.Operating profit surged to 186.70 millions from the corresponding previous quarter of 144.01 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1327.30 1152.52 15.17 2526.66 2262.08 11.70 4659.30 4276.02 8.96
Other Income 26.11 12.19 114.19 54.69 19.08 186.64 67.06 30.94 116.74
PBIDT 186.70 144.01 29.64 353.20 274.75 28.55 596.01 577.86 3.14
Interest 1.15 4.36 -73.62 4.65 9.18 -49.35 14.17 12.90 9.84
PBDT 185.55 139.65 32.87 348.55 265.57 31.25 581.84 241.45 140.98
Depreciation 29.05 30.75 -5.53 56.61 61.00 -7.20 121.47 129.65 -6.31
PBT 156.50 108.90 43.71 291.94 204.57 42.71 460.37 111.80 311.78
TAX 34.41 25.64 34.20 71.85 54.44 31.98 74.76 61.70 21.17
Deferred Tax -2.86 -2.12 34.91 -1.90 -2.19 -13.24 -26.57 13.28 -300.08
PAT 122.09 83.26 46.64 220.09 150.13 46.60 385.61 50.10 669.68
Equity 108.97 108.97 0.00 108.97 108.97 0.00 108.97 64.11 69.97
PBIDTM(%) 14.07 12.50 12.57 13.98 12.15 15.09 12.79 13.51 -5.34

Windlas Biotech Share Price

794.90 -7.65 (-0.95%)
23-Jan-2026 12:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.55
Dr. Reddys Lab 1242.60
Cipla 1382.70
Zydus Lifesciences 888.55
Lupin 2145.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×